STOP-FSGS

Speed Translation-Oriented Progress to Treat FSGS

Idiopathic (primary) FSGS is a rare disease affecting an estimated 2,000 people in Germany. Its secondary form represents a major cause for irreversible loss of renal function and life-long need for dialysis or transplantation.

continue

CONNECT-GENERATE

German Network for Research on Autoimmune Encephalitis

The research network CONNECT-GENERATE aims at improving the diagnosis and treatment of people with autoimmune encephalitis, a rare but treatable form of brain inflammation.

continue

HiChol

Translational network for Hereditary Intrahepatic Cholestasis

Defective bile formation is referred to as cholestasis and can be caused by mutations in genes important for bile formation in the liver. Cholestasis as result of genetic variants is referred to as hereditary intrahepatic cholestasis and comprises a heterogeneous group of rare disorders.

continue

Treat-ION

New Therapies for Neurological Ion Channel and Transporter Disorders

Treat-ION represents a network of clinicians and scientists across Germany to advance the knowledge about recognizing and treating rare neurological ion channel and transporter disorders. Those comprise a variety of neuropsychiatric diseases and symptoms including developmental delay, epilepsy, episodic and chronic ataxia, migraine and others.

continue

MyPred

Network for young individuals with syndromes predisposing to myeloid malignancies

During the last decade, an increasing number of novel genetic disorders with predisposition to myeloid malignancy in young individuals has been identified. Like the inherited bone marrow failure syndromes, some of these disorders are associated with other organ dysfunction.

continue

TreatHSP.net

Translational research on Hereditary Spastic Paraplegias

Hereditary Spastic Paraplegias (HSP) are clinically and genetically highly heterogeneous neurodegenerative disorders primarily affecting the long axons of the corticospinal tract, leading to progressive lower limb spasticity and weakness.

continue

NEOCYST

Network of Early Onset Cystic Kidney Disease

Hereditary cystic kidney diseases are among the most common causes of chronic renal failure in children. As a multidisciplinary network of clinicians, geneticists and basic scientific researchers, NEOCYST is dedicated to the comprehensive research and improved care of patients.

continue

GAIN

German network for multi-organ autoimmune diseases

Multi-organ autoimmune diseases belong to the “ultra-rare” disorders and have only recently been recognized being caused by monogenetic mutations in immune-regulatory genes. Patients are typically characterized by multi-organ inflammation

continue

ADDRess

Translational Research for Persons with Abnormal DNA Damage Response

Disorders with Abnormal DNA Damage Response (DADDR) are rare genetic conditions with impaired DNA repair or maintenance. A shared feature among affected individuals is a strongly increased cancer risk. Treatment is commonly complicated due to the underlying genetic defect.

continue

Translational research on rare diseases

Many of the approximately 8000 rare diseases are still poorly understood. For this reason, research projects in the field of rare diseases are working together at many different locations in Germany and with international partners to jointly improve diagnostics and develop new therapies. The aim is to translate promising scientific findings into clinical application in order to improve the care situation for people with rare diseases. In this translational research approach, the patient side is included in the planning and implementation.

The Research for Rare networks have been funded by the Federal Ministry of Education and Research (BMBF) since 2003.


Following the 12th ECRD (15 -16 May 2024), you can help to shape the future of rare diseases in Europe by signing the open letter to create a solid legacy for the future EU rare disease policy.


SAVE THE DATE: R4R – YOUNG RESEARCHERS WORKSHOP  — 24/25 March 2025

Website Symposium: The Translational Science of Rare Diseases – From Rare to Care IV
3 – 5 May 2023, Evangelische Akademie Tutzing
programme booklet

For current information and calls please see German version of the site